Cite
Lee MS, Mahmud E, Ang L, et al. Comparison of sirolimus-, paclitaxel-, and everolimus-eluting stent in unprotected left main coronary artery percutaneous coronary intervention. J Saudi Heart Assoc. 2013;25(2):75-8doi: 10.1016/j.jsha.2013.03.001.
Lee, M. S., Mahmud, E., Ang, L., Lluri, G., Cheng, R. K., Aragon, J., & Sheiban, I. (2013). Comparison of sirolimus-, paclitaxel-, and everolimus-eluting stent in unprotected left main coronary artery percutaneous coronary intervention. Journal of the Saudi Heart Association, 25(2), 75-8. https://doi.org/10.1016/j.jsha.2013.03.001
Lee, Michael S, et al. "Comparison of sirolimus-, paclitaxel-, and everolimus-eluting stent in unprotected left main coronary artery percutaneous coronary intervention." Journal of the Saudi Heart Association vol. 25,2 (2013): 75-8. doi: https://doi.org/10.1016/j.jsha.2013.03.001
Lee MS, Mahmud E, Ang L, Lluri G, Cheng RK, Aragon J, Sheiban I. Comparison of sirolimus-, paclitaxel-, and everolimus-eluting stent in unprotected left main coronary artery percutaneous coronary intervention. J Saudi Heart Assoc. 2013 Apr;25(2):75-8. doi: 10.1016/j.jsha.2013.03.001. Epub 2013 Mar 14. PMID: 24174850; PMCID: PMC3809457.
Copy
Download .nbib